Monday, March 30, 2020 Daily Archives

Robust Stable Line Platform for Biologics Development

This webcast features: Dr. Sean Liour, Vice President for Project Management, GenScript ProBio A cell line platform can provide the best solution for the biopharmaceutical target. This webinar explains how to develop a robust stable line platform for CMC projects. GenScript’s biologics platform can provide one-stop service of CMC for the biopharmaceutical target. Just fill out the form below to watch the recorded webcast now.

Lonza media launch to support Sf9 insect cells for gene therapy production

Insect-based expression systems remain effective in making gene therapies says Lonza as it launches a medium specifically to produce Adeno Associated Virus (AAV) in Spodoptera Frugiperda (Sf9) cells. According to Lonza, the TheraPEAK SfAAV Medium is the first chemically defined, non-animal origin medium designed specifically for the production of AAV in Sf9 insect cells for gene therapy applications. “This medium is chemically defined and we have compared its performance with four other media on the market currently. It allows for…

Sensationalist press propagating unfounded COVID-19 therapies, says ISCT

Industry consortium the International Society for Cell & Gene Therapy (ISCT) has warned of the dangers of unproven therapies as unscrupulous players look to take advantage of COVID-19 uncertainties. The 1918 Spanish flu outbreak saw the advocation of a host of unproven remedies by the media and advertising firms. These included tobacco, heroin, cocaine, laxatives, malted milk, and literal snake oil. Over a hundred years on with the world caught up in another pandemic, quack remedies and snake oil are…